Pharmaceutical Technology

MAY 19, 2023

While MS is not a terminal diagnosis, the effect of the disease on the CNS can significantly impact patients’ independence and disturb their daily lives. DMTs for MS have a high price tag, particularly in the US. However, they cannot provide a cure and have a very limited impact on halting disease progression.

Prospecting 98

Prospecting Marketing Patients Leads 98

World of DTC Marketing

JUNE 23, 2021

Alzheimer’s really is a devastating diagnosis, and if Biogen had actually produced a game-changing product to slow its worst symptoms, it would have an immeasurable impact on millions of lives. Not to mention the $56,000 annual price tag. What’s more, 40 percent of those subjects suffered side effects, including severe brain swelling.

FDA 218

FDA Side effects Physicians Patients 218

PM360

OCTOBER 13, 2023

Another capability made possible by fine-tuning is the enhancement of content tagging. Content tagging has always been a labor-intensive task. Auto-tagging ensures that the right content efficiently reaches the right customers. Fine-tuning models can target domains and generate prompts to tag the content into relevant topics.

Marketing 64

Marketing Specialization Healthcare Healthcare 64

Pharmaceutical Technology

JULY 14, 2022

Due to the high price tags associated with these speciality medicines, innovators have naturally favoured big markets with high GDP such as the US and EU-5 (Germany, France, Spain, Italy, and the UK). “The Go-to-market strategies. The choice of where to launch an orphan drug is an important and difficult decision.

Medicine 59

Medicine Marketing Specialization Pharma 59

World of DTC Marketing

DECEMBER 13, 2021

As cancer survival rates rise, so do the price tags of life-saving treatments. OPENING: American cancer patients spent more than $21 billion on their care in 2019. billion included out-of-pocket costs of $16.22 billion and patient time costs of $4.87 Some cancer patients may face out-of-pocket costs of nearly $12,000 a year for one drug.

Food and Drug Administration 55

Food and Drug Administration Food Medical Insurance 55

European Pharmaceutical Review

MAY 11, 2023

2 Treating SMA can be challenging because “early signs can be difficult to recognise, delaying diagnosis and treatment,” according to Dr Tauscher-Wisniewski. Rare, genetic diseases like SMA are prime targets for gene therapy, but by their very nature, early signs can be difficult to recognise, delaying diagnosis and treatment.

Food and Drug Administration 72

Food and Drug Administration Government Healthcare Healthcare 72

Cadensee

JANUARY 1, 2022

And eventually, you get a very basic diagnosis after a few minutes of the visit. And they do the diagnosis as part of that. It's already tagged by clinicians with the diagnosis, so you have to do the machine learning and the engineering side. So, waking up in the mornings, seeing that she's not feeling well.

Marketing 52

Marketing Physicians Medical Healthcare 52